Financhill
Back

United Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.

United Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 367.84 Buy
20-day SMA: 378.81 Sell
50-day SMA: 364.96 Buy
200-day SMA: 302.48 Buy
8-day EMA: 371.43 Sell
20-day EMA: 373.56 Sell
50-day EMA: 365.18 Buy
200-day EMA: 316.47 Buy

United Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 47.51 Sell
Chaikin Money Flow: -453533 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (355.35 - 392.45) Sell
Bollinger Bands (100): (329.63 - 371.07) Buy

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for United Therapeutics Stock

Is United Therapeutics Stock a Buy?

UTHR Technical Analysis vs Fundamental Analysis

Buy
54
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy or a Sell?

United Therapeutics Stock Info

Market Cap:
16.46B
Price in USD:
368.66
Share Volume:
509.07K

United Therapeutics 52-Week Range

52-Week High:
417.82
52-Week Low:
208.62
Buy
54
United Therapeutics (UTHR) is a Buy

United Therapeutics Share Price Forecast

Is United Therapeutics Stock a Buy?

  • United Therapeutics share price is 368.66 while UTHR 8-day exponential moving average is 371.43, which is a Sell signal.
  • The stock price of UTHR is 368.66 while United Therapeutics 20-day EMA is 373.56, which makes it a Sell.
  • United Therapeutics 50-day exponential moving average is 365.18 while UTHR share price is 368.66, making it a Buy technically.
  • UTHR stock price is 368.66 and United Therapeutics 200-day simple moving average is 316.47, creating a Buy signal.

Fundamental Analysis of United Therapeutics

Is United Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.71 per share, and an increase next year of $2.60 per share.

Technical Analysis of United Therapeutics

Should I short United Therapeutics stock?

* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.